Pliant Therapeutics Inc. (PLRX)

1.40

-2.04 (-59.30%)

At close: Mar 03, 2025, 3:59 PM

1.48

6.09%

After-hours: Mar 03, 2025, 04:58 PM EST

Pliant Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-161.34M	-123.32M	-97.26M	-41.53M	-631K	-30.28M	-18.33M
Depreciation & Amortization	1.84M	1.82M	1.53M	1.31M	1.11M	666K	292K
Stock-Based Compensation	44.48M	22.6M	10.44M	3.9M	1.83M	228K	33K
Other Working Capital	-3.7M	5.55M	-1.25M	-17K	50K	294K	893K
Other Non-Cash Items	-2.6M	52K	2.93M	266K	12.2M	1.05M	191K
Deferred Income Tax	n/a	n/a	n/a	n/a	-12.2M	n/a	n/a
Change in Working Capital	1.25M	4.22M	6.92M	-1.21M	-5.06M	1.05M	893K
Operating Cash Flow	-116.36M	-94.63M	-75.44M	-37.27M	-2.75M	-28.33M	-16.92M
Capital Expenditures	-921K	-1.76M	-1.95M	-1.53M	-964K	-2.32M	-1.41M
Acquisitions	n/a	148.44M	-75.65M	209.33M	254K	n/a	n/a
Purchase of Investments	-583.07M	-325.72M	-219.89M	-322.61M	-51.97M	n/a	n/a
Sales Maturities Of Investments	456.98M	177.27M	295.54M	113.27M	35M	n/a	n/a
Other Investing Acitivies	n/a	-148.44M	75.65M	-209.33M	-254K	n/a	n/a
Investing Cash Flow	-127.01M	-150.2M	73.7M	-210.87M	-17.93M	-2.32M	-1.41M
Debt Repayment	n/a	10M	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	-12K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-847K	216.85M	-457K	52.02M	45.37M	174.67M	20.02M
Financial Cash Flow	274.4M	226.85M	2.53M	213.21M	45.54M	87.35M	20.01M
Net Cash Flow	31.03M	-17.98M	783K	-34.92M	24.86M	56.7M	1.68M
Free Cash Flow	-117.28M	-96.39M	-77.4M	-38.8M	-3.71M	-30.65M	-18.33M